Akili Interactive Labs
http://www.akiliinteractive.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Akili Interactive Labs
CTA’s Standards For Digital Therapeutics Clears Up ‘Industry Confusion’
The Consumer Technology Association hopes its newly developed standard for digital therapeutics will clear up industry confusion and encourage the adoption of these treatments.
Digital Health Roundup, August/September 2021: Record Digital Health Funding Q1-3 Of $21.3Bn, AAOS Highlights, Regulatory Updates
In this roundup of developments in digital health, we highlight the key news and announcements from August and September.
Digital Health Roundup, July 2021: Exec Chat With DTA, Start-Ups Grab New Funds, Agency Nods
In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from July.
Akili Pays $37.5M To License Tali’s Tech For Early Childhood Attention Impairments
Tali’s video game assesses and improves attention in children three to eight years old. Akili markets the EndeavorRx prescription video game therapy to improve attention function in children ages eight to 12. The deal will help Tali commercialize its technology in the US.
Company Information
- Industry
- Digital Health
- Pharmaceuticals
-
Medical Devices
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
- Rehabilitation Equipment and Devices